MedTrace Logo

Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL)

NCT02076516 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-03-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of the CORACTO® (Rapamycin®-Eluting coronary stent delivery system) for the treatment of up to two de novo lesions or restenotic post-PTCA (non-stented) lesions located in up to two epicardial native coronary arteries (maximum one lesion per vessel) suitable for treatment with stents from 2.5 to 4.0 mm in diameter \< than 15 mm suitable for treatment with a single CORACTO® stent in a population of 100 patients.

Conditions

Interventions

DEVICE

Drug-eluting stent: CORACTO®

Sponsors & Collaborators

  • Alvimedica

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-10-31
Completion
2015-05-31

Countries

  • Belgium
  • France
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02076516 on ClinicalTrials.gov